InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,006.19
(
-1.29%
)
US TECH 100
16,762.80
(
-1.74%
)
Dow Jones
37,823.22
(
-1.66%
)
Brent Oil
86.62
(
-0.69%
)
Bitcoin
63,399.17
(
-1.37%
)
Post# of 251590
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Bickema

Send PM Follow Ignore
Followers 20
Posts 1631
Boards Moderated 0
Alias Born 11/10/2010

Bickema

Re: None

Wednesday, 07/01/2015 2:54:37 PM

Wednesday, July 01, 2015 2:54:37 PM

Post# of 251590
"A total of 3472 drugs were Orphan drug (OD) designated in the last 32 odd years where data is available. Out of these, a mere 495 actually went on to receive orphan drug status in the market. That is 14%, or roughly 1 in 7 applications..."

From a seeking alpha article titled Premarket Biotech Digest. http://seekingalpha.com/article/3296295-premarket-biotech-digest-gerons-sharp-gain-bayer-essure-aes-juno-moves-higher
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up